Programme
Provisional Programme
| 07:00-17:00 | REGISTRATION | |
| BREAKFAST SYMPOSIA | ||
| 08:30-09:30 |
SASMO: Pfizer Topic: Next generation treatment in ALK positive NSCLC: The era of targeted therapies. Speaker: Dr Rosario Garcia Campelo Chair: Dr Sze Wai Chan |
SASCeTS: THERMO FISHER Topic: Genetic Characterization of Lymphoid cancers using a newly developed Community Next Generation Sequencing Panel |
| SESSION 1 | ||
| 10:00-12:30 |
Joint Plenary Chairs: Prof Estelle Verburgh and Prof Georgia Demetriou |
DKMS Symposium Chair: Erna West |
| 10.00-10:05 | Opening Dr Devan Moodley and Dr Justin Du Toit |
DKMS Symposium Opening Dr Alexander Schmidt |
| 10:05-10:30 | Update on BCell Malignancies Professor Stephan Opat |
Meeting Lifesavers Kwazi Mhlongo |
| 10:30-11:10 | Hodgkins lymphoma. Brentuximab vedotin in first line. Dr Anna Sureda |
Apheresis and processing SANBS Dr Tanya Glatt Dr Yona Skosana |
| 11:10-11:30 | REFRESHMENT BREAK | |
| 11:30-12:00 | Beyond remission: secondary primary malignancies in patients with lymphoma post auto transplant Dr Carmelo Gurnari |
History of unrelated donor registries – impact on transplant journey Sr Gabi Rall |
| 12:00-12:30 | Lymphoma genomics Professor Stephan Opat |
DKMS Patient Services Kwazi Mhlongo |
| 12:30-13:30 | REFRESHMENT BREAK | |
| LUNCH SYMPOSIA | ||
| 12:30-13:30 |
SASMO: Novartis Topic: The Era of CDK4/6 inhibitors in the management of early breast cancer |
SASCeTS: Janssen Topic: Chronic lymphocytic leukaemia Chair: Dr Andrew McDonald |
| SESSION 2 | ||
| 13:30-15:30 |
SASMO: BREAST TRACK Chairs: Dr Aaron Ndhlumi & Dr KeoTabane |
SASCeTS: DONOR SELECTION Chairs: Michael Cass |
| 13:30-14:00 | Genomic Signatures in Breast Cancers Dr Martine Piccart |
DKMS Africa: our approach to give more patients in South Africa a second chance at life Dr Theo Gerdener |
| 14:00-14:30 | An approach to a metastatic Breast Cancer patient Prof Guiseppe Curigliano Virtual |
SABMR – Donor experiences and an approach to the minor donor. Prof Galen Switzer |
| 14:30-15:00 | DAC/ADC in breast cancer. Dr Martine Piccart |
Germline mutations in haematological malignancies & impact on donor selection Dr Carmelo Gurnari |
| 15:00-15:30 | NAPBC standards improving quality of care. Dr Tony Nguyen Virtual |
Panel Discussion Facilitated by Dr Julia Pingel |
| 15:30-16:00 | REFRESHMENT BREAK | |
| SESSION 3 | ||
| 16:00-18:00 |
SASMO: Lung Session Chairs: Dr Sze Wai Chan & Dr Jacqueline Hall |
SASCeTS: Bone marrow failure syndromes Chairs: Dr Justin du Toit & Dr Candice Hendricks |
| 16:00-16:30 | How to incorporate the latest data for the treatment of EGFR mutation positive NSCLC Dr Jordi Remon |
HAPLO transplant in Fanconi anaemia with PTCY method. Dr Carmem Bonfim |
| 16:30-17:00 | Approach to resectable NSCLC – eoadjuvant, peri-operative or adjuvant? Dr RG Campelo |
Improving access to allogeneic transplant for AA patients in public sector. Challenges to solutions Dr Thandeka Nkabi Dr Justin du Toit Dr Yasmin Goga |
| 17:00-17:30 | De-escalating strategy – data and practice Dr Jordi Remon |
BMT for Non-malignancies in a developing country Lalith Parmar, President Sankalp India Foundation NPO |
| 17:30-18:00 | Are all anti-PD(L)1 the same in the treatment of NSCLC? Dr RG Campelo |
Brazilian experience on allo transplant in aplastic anaemia/BMFS Dr Carmem Bonfim |
| 18:10-19:00 | SASMO AGM | SASCeTS AGM |
| 19:00-21:00 | EXHIBITORS WELCOME COCKTAIL | |
| 07:00-17:00 | REGISTRATION | |||||
| BREAKFAST SYMPOSIA | ||||||
| 07:30-08:30 |
SASMO: MSD Chair: Dr Omondi Ogude |
SASCeTS: Novartis Chair: Prof Estelle Verburgh |
||||
| SESSION 4 | ||||||
| 09:00-11:00 | Joint Plenary Chairs: Prof Bernardo Rapoport & Prof Estelle Verburgh |
|||||
| 09:00-09:30 | Hodgkins lymphoma Dr Anna Sureda |
|||||
| 09:30-10:00 | Cancer in People Living with HIV Dr Mazvita Muchengeti |
|||||
| 10:00-10:30 | Fertility preservation in South Africa : Utilization , efficacy, and outcomes. Dr Chris Venter |
|||||
| 10:30-11:00 | “Right patient, Right treatment, Right line, Right time” Dr Linda Kelly |
|||||
| 11:00-11:30 | REFRESHMENT BREAK | |||||
| SESSION 5 | ||||||
| 11:30-13:00 | SASMO: HBP Chairs : Dr Omondi Ogude Dr Richard Khanyile |
SASCeTS: Chairs: Dr Justin du Toit |
SASOPh – PHARMACISTS |
NURSES SYMPOSIUM |
||
| 11:30-12:00 | Lessons to be learnt from HCC therapy Dr Mohsen Mokhtar |
GVHD prophylaxis – a shift to PTCY across international centres Dr Jurjen Versluis |
Emergency in Oncology (Extravasation) Carien van der Merwe |
Chemotherapy organ damage Andrea Brummer |
||
| 12:00-12:30 | The place of Interventional radiology in HCC Dr John Cantrell |
An approach to mismatched unrelated donor and haploidentical transplants in a state-of-the-art setting. Prof Thomas Klingebiel |
Pharmaceutical Care Plan and Documentation Razeeya Khan |
Moving from the horror to the symphony. The impact of Narrative Therapy in Oncology. Pieter Le Roux |
||
| 12:30-13:00 | Surgery for HCC: Transplant vs Resection Dr Sharan Rambarran |
MDS/AML with TP53 – to transplant or not? Dr Jurjen Versluis |
Venous access in donor Muriel Wentzel |
|||
| 13:00-14:00 | LUNCH | |||||
| LUNCH SYMPOSIA | ||||||
| 13:00-14:00 |
SASMO: Roche Chair: Dr Devan Moodley |
SASCeTS: Takeda Chair: Dr Michael Cass |
||||
| SESSION 6 | ||||||
| 14:00-16:00 | SASMO: Upper GIT / GE disease Chairs: Dr Ashraf Wadee & Dr Mariza Tunmer |
SASCeTS: CAR Ts Chairs: Dr Pieter de Witt |
SASOPh – PHARMACISTS Chair: Miempie Truter |
NURSES SYMPOSIUM |
||
| 14:00-14:30 | Neo-adjuvant vs adjuvant strategies in Oesphageal malignancies Prof Mohsen Mokhtar |
Update on CAR Ts in Paediatric ALL CAR T CELLS Prof Wing Leung |
Pharmacovigilance Ms Machikoana Phasha |
BACRELBA Eileen Claassens |
||
| 14:30-15:00 | Radiotherapy in upper GIT malignancies Dr Mariza Tunmer |
Access to CAR-T’s in South Africa – work in progress Dr Candice Hendricks |
14:30 – 15:20 15:20 – 15:40
|
|||
| 15:00-15:30 | Surgery for Upper GIT malignancies Dr Leanne Prodehl |
Development of CAR-NK therapy Prof Wing Leung |
Patient Counselling Tegan Bilse |
|||
| 15:30-16:00 | Interventional radiology vs Surgery for Oligometastatic disease. Dr Leeanne Prodehl Dr John Cantrell (Virtual) |
First CAR T trial in SA – Dr Dr David Brittain | ||||
| 16:00-16:30 | REFRESHMENT BREAK | |||||
| SESSION 7 | ||||||
| 16:30-18:00 | SASMO: Proffered Papers Chairs: Dr Gary McMichael & Dr Dalene Geldenhuys |
SASCeTS: Proffered Papers Chair: Dr Sharlene Parasnath |
SASOPh – PHARMACISTS Chair: Johandre Van Jaarsveld |
|||
| 16:30-18:00 | Proffered Papers | Proffered Papers | 16:30 – 17:15 Regulatory aspects of Biosimilars Quinton Barber 17:15 -18:00 Substitution/Interchange ability/Switching Johan Labuschagne |
|||
| 19:30-23:30 | GALA DINNER (Sponsored by Dr Reddy’s) | |||||
| SESSION 8 | ||
| 08:00-10:00 | Joint Plenary Chairs: Dr David Brittain and Dr Yusuf Mayet |
|
| 08:00-08:30 | The Ethics of Bio Banking and Data Mining. Prof Shenuka Singh |
|
| 08:30-09:00 | Health Technology Assessments in Oncology: Who cares? Dr Noluthando Nematswerani |
|
| 09:00-09:30 | Alternative Reimbursements Models as access solutions Gavin Bauer |
|
| 09:30-10:00 | Regulatory issues around advance medicinal therapeutic products Ignatius Viljoen |
|
| BRUNCH SYMPOSIA | ||
| 10:00 – 11:00 | SASMO: Key Oncologics Topic: Nerlynx® for the extended adjuvant treatment of early-stage HR+ & HER2+ breast cancer Speaker: Prof Georgia Demetriou Chair: Dr Rika Pienaar |
SASCeTS: Roche Rethink DLBCL treatment. Navigating new treatments in DLBCL Speaker: Dr Wendy Osborne Chair: Dr David Brittain |
| 11:00 – 11:30 | REFRESHMENT BREAK | |
| SESSION 9 | ||
| 11:30-13:30 | SASMO: Urological Malignancies Chairs: Dr Devan Moodley & Dr Mia Hugo |
SASCeTS: Present & Future Chairs: Dr Jacques Malherbe |
| 11:30-12:00 | Management of early -stage bladder malignancies Dr Amar Challapalli |
Choosing the best donor for PMF Dr Donal McLornan |
| 12:00-12:30 | FDG PET/ PSMA PET / MRI PET / MRI / CT / Bone scan: what to do when? Dr Amar Challapalli |
How I Treat low grade (Follicular) Lymphoma. Dr Wendy Osborne |
| 12:30-13:00 | Optimising outcomes in cystectomy: is the pen mightier than the sword? Dr Justin Howlett |
B-cell receptor targeting and its evolution in the treatment of CLL Prof Martin Trepel |
| 13:00-13:30 | SASMO 2024 Closing | SASCeTS 2024 Closing |
Programme and Topics is subject to change